Eledon Pharmaceuticals, Inc. — Director's Dealing 2021

May 4, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Eledon Pharmaceuticals, Inc. (ELDN)
CIK: 0001404281
Period of Report: 2021-05-03

Reporting Person: Smith Bryan E. (See Remarks)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-05-03	Stock Option (Right to Buy)	$9.91	A	158500	Acquired	2031-05-03	Common Stock (158500)	Direct

Footnotes

F1: This option represents a right to purchase up to 158,500 shares of Common Stock, which option vests with respect to 39,625 shares on May 3, 2022, and then with respect to 6.25% of the underlying shares quarterly over the three year period ending May 3, 2025.